Lung transplantation for pulmonary hypertension: Patient selection and maintenance therapy while awaiting transplantation

Stuart Rich*, Vallerie V. McLaughlin

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Although lung transplantation is considered a definitive treatment of patients with advanced pulmonary vascular disease and pulmonary hypertension, advances in the success of the medical management of patients with pulmonary hypertension make it less clear as to when to refer a patient for transplantation. Coumadin anticoagulation is associated with improved survival in all patients, and calcium channel blockers therapy with improved survival in very select patients. Chronic prostacyclin represents a newer therapy that seems to have a dramatic impact on patients' functional class and survival. As improvements continue in the medical management in pulmonary hypertension, and in survival of patients undergoing lung transplantation, the guidelines for patient selection should be constantly evolving.

Original languageEnglish (US)
Pages (from-to)205-208
Number of pages4
JournalTransplantation Reviews
Volume12
Issue number4
DOIs
StatePublished - Jan 1 1998

Keywords

  • Lung transplantation
  • Prostacyclin
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Lung transplantation for pulmonary hypertension: Patient selection and maintenance therapy while awaiting transplantation'. Together they form a unique fingerprint.

  • Cite this